72.17
Billiontoone Inc Borsa (BLLN) Ultime notizie
BTIG lowers BillionToOne stock price target on valuation multiples - Investing.com
Billiontoone's (BLLN) "Buy" Rating Reiterated at Guggenheim - MarketBeat
Billiontoone (NASDAQ:BLLN) Price Target Lowered to $140.00 at BTIG Research - MarketBeat
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge By Investing.com - Investing.com Canada
BillionToOne Swings To Profit In Q4; Lifts FY26 Guidance - Nasdaq
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge - Investing.com South Africa
Billiontoone (NASDAQ:BLLN) Announces Earnings Results - MarketBeat
Billiontoone Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: BillionToOne’s Q4 2025 sees robust growth, stock dips - Investing.com India
BillionToOne (BLLN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
BillionToOne Raises 2026 Guidance, Aligns Incentive Plan - TipRanks
BillionToOne: Q4 Earnings Snapshot - marketscreener.com
(BLLN) BillionToOne Expects 2026 Revenue Range $430M-$445M, vs. FactSet Est of $405.1M - marketscreener.com
Earnings Flash (BLLN) BillionToOne Posts Q4 EPS $0.11, vs. FactSet Est of $0.06 - marketscreener.com
Earnings Flash (BLLN) BillionToOne, Inc. Reports Q4 Revenue $96.1M, vs. FactSet Est of $87.2M - marketscreener.com
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance - GlobeNewswire
Billiontoone (NASDAQ:BLLN) Trading Down 5.7%Time to Sell? - MarketBeat
BillionToOne Stock at $89: Why a New $19.1 Million Position Could Matter Now - AOL.com
BillionToOne: Overview of Fourth Quarter Financial Results - Bitget
Billiontoone (NASDAQ:BLLN) Trading Up 6%Time to Buy? - MarketBeat
BillionToOne Inc expected to post earnings of 8 cents a shareEarnings Preview - TradingView
BillionToOne (BLLN) Launches Two New Add-ons for Northstar Select - Yahoo Finance
InvestingPro’s Fair Value spotted BillionToOne 46% drop in advance By Investing.com - Investing.com UK
BLLN Should I Buy - Intellectia AI
BLLN PE Ratio & Valuation, Is BLLN Overvalued - Intellectia AI
BillionToOne Stock Slumps 13% in February. Analysts Still See $135 Fair Value - TIKR.com
BillionToOne stock sinks 16% ahead of March earnings: what traders are watching - Bez Kabli
Billiontoone (NASDAQ:BLLN) Reaches New 1-Year LowTime to Sell? - MarketBeat
Five new option listings and three option delistings on February 19th - TipRanks
Natera Accuses Worker Who Went to Competitor of Stealing Secrets - Bloomberg Law News
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - The Manila Times
BillionToOne, Inc. Announces Q4 and Full Year 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative
BillionToOne reaffirms FY25 guidance - MSN
BillionToOne, Inc.Class A common stock (Nasdaq:BLLN) Stock Quote - The Chronicle-Journal
Billiontoone, Inc. (NASDAQ:BLLN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
BillionToOne adds pharmacogenomics, clonal filtering to Northstar cancer test - Mugglehead Investment Magazine
BillionToOne expands liquid biopsy platform with two add-on tests By Investing.com - Investing.com Australia
BillionToOne Expands Northstar Platform with Launch of Two New A - GuruFocus
BillionToOne expands liquid biopsy platform with two add-on tests - Investing.com Nigeria
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - Finviz
BillionToOne, Inc. Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - marketscreener.com
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select® - PR Newswire
BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care - BioSpace
BillionToOne initiated with a Hold at Jefferies - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):